Heterogeneity of Multifunctional IL-17A Producing S. Typhi-Specific CD8+ T Cells in Volunteers following Ty21a Typhoid Immunization by McArthur, Monica A. & Sztein, Marcelo B.
Heterogeneity of Multifunctional IL-17A Producing S.
Typhi-Specific CD8+ T Cells in Volunteers following
Ty21a Typhoid Immunization
Monica A. McArthur
1,2, Marcelo B. Sztein
1,2*
1Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, 2Department of Pediatrics, University of
Maryland School of Medicine, Baltimore, Maryland, United States of America
Abstract
Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever, continues to cause significant morbidity
and mortality world-wide. CD8+ T cells are an important component of the cell mediated immune (CMI) response against S.
Typhi. Recently, interleukin (IL)-17A has been shown to contribute to mucosal immunity and protection against intracellular
pathogens. To investigate multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, we developed
multiparametric flow cytometry methods to detect up to 6 cytokines/chemokines (IL-10, IL-17A, IL-2, interferon-c (IFN-c),
tumor necrosis factor-a (TNF-a) and macrophage inflammatory protein-1b (MIP-1b)) simultaneously. Five volunteers were
immunized with a 4 dose regimen of live-attenuated S. Typhi vaccine (Ty21a), peripheral blood mononuclear cells (PBMC)
were isolated before and at 11 time points after immunization, and CMI responses were evaluated. Of the 5 immunized
volunteers studied, 3 produced detectable CD8+ T cell responses following stimulation with S. Typhi-infected autologous B
lymphoblastoid cell lines (B-LCL). Additionally, 2 volunteers had detectable levels of intracellular cytokines in response to
stimulation with S. Typhi-infected HLA-E restricted cells. Although the kinetics of the responses differed among volunteers,
all of the responses were bi- or tri-phasic and included multifunctional CD8+ T cells. Virtually all of the IL-17A detected was
derived from multifunctional CD8+ T cells. The presence of these multifunctional IL-17A+ CD8+ T cells was confirmed using
an unsupervised analysis program, flow cytometry clustering without K (FLOCK). This is the first report of IL-17A production
in response to S. Typhi in humans, indicating the presence of a Tc17 response which may be important in protection. The
presence of IL-17A in multifunctional cells co-producing Tc1 cytokines (IL-2, IFN-c and TNF-a) may also indicate that the
distinction between Tc17 and Tc1 responses in humans is not as clearly delineated as suggested by in vitro experiments and
animal models.
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Introduction
Salmonella enterica serovar Typhi (S. Typhi), a human restricted
pathogen, is the causative agent of typhoid fever. S. Typhi is a
Gram-negative, facultative intracellular pathogen that poses a
significant threat to public health, particularly in the developing
world [1,2]. Typhoid fever is responsible for an estimated 21
million illnesses and 200,000 deaths annually and increasing
antibiotic resistance among S. Typhi isolates has further exacer-
bated the problem [1,2,3,4,5,6,7,8]. T cells, and particularly
CD8+ T cells are thought to play an important role in the immune
response against S. Typhi by producing interferon-c (IFN-c) and
other T helper (Th) 1/T cytotoxic (Tc) 1 cytokines
[9,10,11,12,13,14,15,16,17], as well as killing S. Typhi infected
cells [10,18]. Additionally, multifunctional CD8+ T cells have
been identified in volunteers immunized with live-attenuated
typhoid vaccine Ty21a [13]. Of note, the latter study has shown
multiphasic cytokine production by CD8+ T cells in response to
human leukocyte antigen E (HLA-E)-restricted antigenic stimula-
tion [13].
Interleukin-17A is a pro-inflammatory cytokine that is involved
in protection against extracellular and intracellular bacterial
pathogens, as well as fungi and viruses [19,20,21,22,23]. IL-17A
and associated Th17 cytokines promotes neutrophil recruitment
via induction of chemokines and granulopoietic factors [19,23].
Additionally, IL-17 has been shown to regulate Th1 responses by
altering IL-12p70 production by dendritic cells [24]. In addition to
Th17, the presence of CD8+ Tc17 cells that produce IL-17A have
recently been described [25,26,27,28].
Therefore, to evaluate the hypothesis that IL-17A may play a
role in protection from S. Typhi infection, we investigated the
presence of IL-17A producing CD8+ T cells in peripheral blood
mononuclear cells (PBMC) obtained from Ty21a recipients
following ex vivo stimulation with S. Typhi-infected autologous B-
lymphoblastoid cell lines (B-LCL) or an S. Typhi-infected HLA-E
restricted cell line. Furthermore, given the prominent role that
multifunctional T cells have been shown to have in the host
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the concomitant production of IL-17A with 5 other cytokines/
chemokines (IL-10, IL-2, IFN-c, tumor necrosis factor-a (TNF-a),
and macrophage inflammatory protein-1b (MIP-1b) as a first step
to investigate the potential role of multifunctional T cells in
protection from S. Typhi infection.
Materials and Methods
Volunteers and Isolation of Peripheral Blood
Mononuclear Cells (PBMC)
PBMC collected from 6 healthy adult volunteers, recruited from
the Baltimore-Washington area and University of Maryland,
Baltimore campus, were used in this study. Written informed
consent was obtained and all procedures were approved by the
University of Maryland, Baltimore IRB. PBMC were isolated
immediately after blood draws by density gradient centrifugation
and cryopreserved in liquid nitrogen following standard tech-
niques [18,32].
Target/stimulator Cells
Epstein Barr virus (EBV)-transformed B-LCL were generated
from PBMC obtained from Ty21a vaccinees and control
volunteers as previously described [18]. Briefly, B-LCL were
established using supernatants from the B95.8 cell line (ATCC
CRL1612; American Type Culture Collection) as the source of
EBV. PBMC from each volunteer were incubated with EBV
containing supernatant and cyclosporine (0.5 mg/mL; Sigma,
Saint Louis, MO) at 37uC with 5% CO2 for 2–3 weeks. B-LCL
were maintained in culture or cryopreserved until use.
An HLA class I-defective B cell line transfected with HLA-E
fused to the HLA-A2 leader peptide (therefore expressing the
HLA-E*0101 allele, but not HLA-A, -B, -C on the cell surface),
721.221.AEH (AEH cells), were provided by Dr. D. Geraghty
[9,13,33]. AEH cells were maintained in RPMI 1640 media
(Gibco, Carlsbad, CA) supplemented with 100 U/mL penicillin
(Sigma), 100 mg/mL streptomycin (Sigma), 50 mg/mL gentamicin
(Gibco), 2 mM L-glutamine (Gibco), 10 mM HEPES buffer
(Gibco), 10% fetal bovine serum (Gemini Bioproducts, West
Sacramento, CA), and 100 mg/mL hygromycin (Sigma).
Infection of Target/stimulator Cells
Target cells were infected by incubation with wild-type S. Typhi
strain ISP1820 in RPMI without antibiotics for 3 hours at 37uC
with 5% CO2 as previously described [18]. On the day following
infection the cells were gamma irradiated (6000 rad). To confirm
that targets were infected with S. Typhi, cells were stained with
anti-Salmonella common structural Ag (CSA-1)-FITC (Kierkegaard
& Perry, Gaithersburg, MD) and analyzed by flow cytometry using
an LSR-II instrument (BD). The percentage of cells infected with
S. Typhi was recorded for each experiment. Infected targets were
only used if infection was .30% of viable cells.
Ex vivo Stimulation
PBMC were thawed and rested overnight at 37
oC, 5% CO2 in
complete media (RPMI 1640 media (Gibco) supplemented with
100 U/mL penicillin (Sigma), 100 mg/mL streptomycin (Sigma),
50 mg/mL gentamicin (Gibco), 2 mM L-glutamine (Gibco),
2.5 mM sodium pyruvate (Gibco), 10 mM HEPES buffer (Gibco),
and 10% fetal bovine serum (Gemini Bioproducts,)) at a
concentration of 1610
6 cells/mL in 6 or 12 well plates. Cells
were then resuspended in complete media and stimulated with S.
Typhi-infected autologous B-LCL or S. Typhi-infected HLA-E
restricted AEH cells. Media alone and uninfected autologous B-
LCL or HLA-E restricted AEH cells were used as negative
controls. Staphylococcal enterotoxin B (SEB) (10 mg/mL; Sigma)
was used as a positive control. Cells were incubated at 37uCi n5 %
CO2. After 2 hours, Golgi Stop (containing monensin) and Golgi
Plug (containing brefeldin A) from BD were added at concentra-
tions of 0.5 ml/mL and cultures continued overnight at 37uCi n
5% CO2.
Surface and Intracellular Staining for Flow Cytometric
Analyses
Following stimulation as described above, cells were plated in
96-well V-bottom plates for staining. Cells were washed once with
staining buffer (phosphate buffered saline with 0.5% BSA and
0.1% sodium azide) and stained for live/dead discrimination using
Invitrogen LIVE/DEAD fixable violet dead cell stain kit
(Invitrogen, Carlsbad, CA). Fc receptor blocking was performed
with human immunoglobulin (3 mg/mL; Sigma) followed by
surface staining, performed as previously described [13]. Briefly,
cells were stained with CD14-Pacific Blue (TuK4, Invitrogen) and
CD19-Pacific Blue (SJ25-C1, Invitrogen), CD3-biotin (UCHT1,
Beckman Coulter, Danvers, MA), CD4-Qdot 655 (S3.5, Invitro-
gen), CD8-Qdot 705 (3B8, Invitrogen), CD45RA-Qdot 605
(MEM56, Invitrogen), and CD62L-PE-Cy5 (Dreg 56, BD,
Franklin Lakes, NJ) at 4uC for 30 minutes. Staining with
streptavidin-Pacific Orange (Invitrogen) was performed for panels
that included biotin-conjugated monoclonal antibodies for 30
minutes at 4uC. The cells were then fixed and permeabilized using
IC fixation and permeabilization buffers from eBiosciences
according to manufacturer’s recommendations. Intracellular
staining with IL-17A-PerCP-Cy5.5 (eBio64DEC17, eBioscience),
IL-2-PE-Cy7 (MQ1-17H12, BD), IFN-c-Alexa 647 or APC-Alexa
750 (B27, BD or Invitrogen), TNF-a-Alexa 700 (MAb11, BD), IL-
10-FITC (127107, R&D, Minneapolis, MN), MIP-1b-APC
(24006, R&D), and CD69-PE (FN50, eBioscience) was performed
at 4uC overnight. After staining, cells were fixed in 1%
paraformaldehyde and stored at 4uC until analyzed. Cells stained
with the 13-color panels described above were analyzed by flow
cytometry using a customized LSRII flow cytometer (BD). Flow
cytometry data were analyzed using WinList version 7 (Verity
Software House, Topsham, ME) and FLOCK (ImmPort, NIH
web site www.immport.org) software packages. Graphs were
generated using GraphPad Prism version 5.03 (Graphpad
Software, San Diego, CA).
Figure 1. Detection of intracellular cytokines/chemokines produced by CD8+ T cell memory subsets in response to stimulation with
S. Typhi-infected autologous B-LCL. Histograms from a representative volunteer (53 s at day 7 post infection) showing the production of 6
cytokines/chemokines by memory T cell subsets following stimulation with S. Typhi-infected autologous B-LCL. CD69 (a marker of recent activation) is
displayed on the y-axis and each of the 6 cytokines/chemokines measured are displayed on the x-axes. Column 1 represents total CD8+ T cells,
column 2 represents T central memory (TCM; CD62L+ CD45RA-), column 3 represents T naı ¨ve (TN; CD62L+ CD45RA+), column 4 represents T effector
memory (TEM; CD62L- CD45RA-), and column 5 represents T effector memory CD45RA+ (TEMRA; CD62L- CD45RA+). The percentage of positive cells is
shown for the indicated region in each cytogram.
doi:10.1371/journal.pone.0038408.g001
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All tests were performed using GraphPad Prism version 5.03
(Graphpad Software). Comparisons between groups were per-
formed using Mann-Whitney and Kruskal-Wallis tests. In flow
cytometry experiments a response was considered significant if the
differential in the number of positive events between experimental
(S. Typhi-infected) and negative control (non-infected) cultures was
significantly increased by Chi-square tests. P values ,0.05 were
considered significant.
Results
Kinetics of S. Typhi-specific CD8+ T Cells in Response to
Stimulation with S. Typhi-infected Autologous Cells
Previous studies have indicated that CD8+ T cells are a major
component of the CMI response to S. Typhi [10,14,15,18].
Therefore we set out to determine the kinetics of CD8+ T cell
responses to in vitro stimulation with autologous S. Typhi-infected
cells following Ty21a immunization. Five healthy adult volunteers
received 4 doses of the licensed oral, live-attenuated S. Typhi
vaccine Ty21a on days 0, 2, 4, and 7. One volunteer did not
receive Ty21a (negative control). PBMC were isolated before
immunization and at 11 time-points up to 1 year after
immunization (days 2, 4, 7, 10, 14, 28, 42, 56, 120, 180, and
360). Following isolation, PBMC were stimulated with S. Typhi-
infected autologous B-LCL. Uninfected B-LCL and SEB were
used as negative and positive controls respectively. PBMC were
stained with monoclonal antibodies against CD3, CD4, CD8,
CD14, CD19, CD45RA, and CD62L followed by intracellular
staining for CD69, IL-10, IL-17A, IL-2, IFN-c, TNF-a, and MIP-
1b. Due to unavailability of the antibody, MIP-1b staining was not
performed in 2 of the volunteers (48 s and 50 s). The samples were
then analyzed by multichromatic flow cytometry. The gating
strategy is shown in Figure S1. CD3+ CD8+ T cells were
categorized by their expression of CD62L and CD45RA into
naı ¨ve T cells (TN; CD62L+ CD45RA+), T central memory cells
(TCM; CD62L+ CD45RA-), T effector memory (TEM; CD62L-
CD45RA-), and T effector memory CD45RA+ (TEMRA; CD62L-
CD45RA+) as previously described (Figure S1) [34]. We observed
the intracellular production of multiple cytokines to be predom-
inantly by the TEM subset with a smaller contribution by the
TEMRA subset (Figure 1).
Low levels of cytokine production were detected in PBMC
stimulated with uninfected autologous B-LCL and this background
was subtracted to calculate the S. Typhi-specific response. There
was some variable baseline responsiveness on day 0 in most
volunteers, likely due to cross-reactivity with other enteric Gram
negative rods. Therefore, the net value (day x post immunization –
day 0) was used to normalize the data. We found that 3 of the 5
immunized volunteers (60%) showed detectable intracellular
cytokine responses above baseline responsiveness at day 0
(Figure 2 and Figure S2). This is consistent with our previous
data using PBMC from subjects immunized with Ty21a and,
interestingly, with most field studies which report a vaccine
efficacy of 65–70% [10,13,35]. Intracellular IL-10 was not
detected in any of the volunteers at any time-point. MIP-1b was
measured in only 2 of the 3 responders (53 s and 54 s). There was
significant production of MIP-1b by both TEM and TEMRA from
volunteer 53 s (Figure 2 A & B); however, volunteer 54 s produced
no detectable MIP-1b (Figure 2 C & D). CD8+ TEM from all 3
volunteers (53 s, 54 s, and 50 s) produced high levels of TNF-a
and IFN-c (5–15% of circulating TEM at the peak times), followed
by IL-2 (4–8% of circulating TEM at the peak times), and then IL-
17A (2–5% of circulating TEM at the peak times) (Figure 2).
Intracellular IL-17A production was found in all 3 responders with
kinetics that followed those of the other cytokines/chemokines
measured (except MIP-1b) (Figure 2). The kinetics of the responses
varied considerably among volunteers; however, all 3 volunteers
showed bi- or tri-phasic responses. Early peaks were observed in
volunteers 53 s and 50 s at days 4 to 7 post immunization (Figure 2
A, B, E, & F). In volunteer 53 s, additional peaks were observed at
days 42 and 180–360 post immunization (Figure 2 A). The kinetics
of MIP-1b differed from the kinetics of the other 5 cytokines with
only 2 peaks at day 4 to 7 and days 28 to 56 (Figure 2 A).
Volunteer 54 s had a bi-phasic response without an early peak.
Peaks occurred at days 42 and 120 post immunization (Figure 2 C
& D). In addition to the early peak at day 4 post immunization,
volunteer 50 s demonstrated a peak from days 10 to 28 and a third
peak at days 56–120 post immunization. The peaks in volunteer
50 s responses were not as dramatic as those observed in volunteer
53 s and 54 s.
The TEMRA responses were generally lower in magnitude than
TEM responses in volunteer 53 s, essentially absent in volunteer
54 s, and substantially lower than TEM responses in volunteer 50 s
(Figure 2 B, D, & F). There were also some differences in the
kinetics of the TEM and TEMRA responses (Figure 2 A–F).
Differences in Kinetics of S. Typhi-specific HLA-E
Restricted CD8+ T Cells
Here we investigated whether IL-17A was produced following
stimulation by HLA-E restricted CD8+ T cells, as well as defined
the kinetics of this response. As described for PBMC stimulated
with S. Typhi-infected autologous B-LCL, PBMC from immu-
nized volunteers were stimulated with the S. Typhi-infected HLA-
E restricted cell line (721.221.AEH), stained, and analyzed by
multichromatic flow cytometry. The same gating strategy was
applied (Figure S1). We found that TEM and to a lesser extent
TEMRA subsets were the major sources of intracellular cytokine
production (Figure 3). In contrast to stimulation with S. Typhi-
infected autologous B-LCL, HLA-E restricted stimulation resulted
in responses in 2 of the volunteers, 53 s and 54 s (Figure 4 and
Figure S3). This is unlikely to be the result of technical difficulties.
For all volunteers, including 50 s, there were equivalent viability
and percentages of S. Typhi-infected autologous B-LCL and HLA-
E restricted AEH cells (data not shown). With the exception of
MIP-1b production by volunteer 53 s, the levels of detectable
intracellular cytokines were lower in response to HLA-E restricted
stimulation compared to autologous B-LCL stimulation (Figures 2
& 4). As seen following stimulation with S. Typhi-infected
autologous B-LCL, MIP-1b production was the predominant
response by volunteer 53 s (Figure 4 A & B). CD8+ TEM from
volunteer 54 s only produced MIP-1b at day 7 post immunization
Figure 2. Kinetics of intracellular cytokine/chemokine production following stimulation of PBMC with S. Typhi-infected autologous
B-LCL. Intracellular cytokine/chemokine production is shown as the percentage of positive cells. Responses are expressed as net values with day 0
subtracted to normalize for differences in base-line responses to S. Typhi in different volunteers. A) CD8+ TEM cells for volunteer 53 s B) CD8+ TEMRA
cells for volunteer 53 s C) CD8+ TEM cells for volunteer 54 s D) CD8+ TEMRA cells for volunteer 54 s E) CD8+ TEM cells for volunteer 50 s F) CD8+ TEMRA
cells for volunteer 50 s. Increases of .0.5% cytokine positive cells over uninfected targets were found to be consistently statistically significant
(P,0.01) by chi-square analyses. * MIP-1b not measured.
doi:10.1371/journal.pone.0038408.g002
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the highest percentage of cells with detectable intracellular
cytokines, followed by IL-2 (2.87–3.85%) and IL-17A (2.64–
4.71%) at peak time points (Figure 4). Although the kinetics were
also bi- or tri-phasic, there were differences between the peak time-
points following stimulation with S. Typhi-infected autologous B-
LCL and HLA-E restricted cells (Figures 2 & 4). Volunteer 54 s
showed a bi-phasic response to stimulation with S. Typhi-infected
autologous B-LCL (Figure 2 C & D) but a tri-phasic response to S.
Typhi-infected HLA-E restricted cells (Figure 4 C & D).
Differences in the Kinetics of IL-17A Producing CD8+ T
Cells in Response to Stimulation with S. Typhi-infected
Autologous or HLA-E Restricted Cells
This is, to our knowledge, the first description of CD8+ T cells
producing IL-17A in response to S. Typhi. IL-17A was produced
by all responding volunteers in response to stimulation with S.
Typhi-infected autologous B-LCL (53 s, 54 s, and 50 s) and HLA-
E restricted (53 s and 54 s) cells. TEM were the predominant
source of IL-17A, with intracellular IL-17A also detected in
TEMRA of volunteer 53 s (Figure 5 A & B). Only a small amount of
intracellular IL-17A was detected in TEMRA from volunteer 54 s in
response to S. Typhi-infected HLA-E restricted cells on days 28
and 180 (Figure 5 D). The kinetics of IL-17A production were
consistent with those of other cytokines measured (e.g, IL-2, IFN-
c, etc) and demonstrated bi- or tri-phasic responses that differed
according to the S. Typhi-infected targets used in the stimulation
(Figure 5).
S. Typhi-specific CD8+ T Cells are Primarily
Multifunctional
Because recent reports suggested that multifunctional T cells are
likely to play a prominent role in protection from infection
[25,26,27], we next investigated the multifunctionality of CD8+ T
cell responses to Ty21a. Using the FCOM function of WinList
(Verity software) we analyzed all possible combinations (64 total) of
the 6 cytokines/chemokines measured (IL-10, IL-17A, IL-2, IFN-
c, TNF-a, and MIP-1b) at each time-point. Only combinations
with at least 1 time-point $0.5% of CD8+ TEM or TEMRA
cytokine positive cells are shown. This percentage represents a
minimum of ,10–50 events for TEMRA and TEM respectively.
Results from a representative volunteer (53 s) are shown in
response to stimulation with S. Typhi-infected autologous cells
(Figure 6) and S. Typhi-infected HLA-E restricted cells (Figure 7).
Data from the other responding volunteers are shown in Figures
S3,S4,S5. Due to the complexity of the data (64 combinations for
each of 12 time-points) we determined the median value for each
combination that was $0.5% based on all time-points (Figures 6A,
7A, S3A, S4A, S5A). Each combination is shown on the X-axis
with the values from each time-point (in % positive cells) on the Y-
axis. The median value was determined for each combination and
the kinetics of the top 5 combinations are shown (Figures 6B, 7B).
Multifunctional responses predominated over single cytokine
producing cells in all volunteers (Figures 6 and 7, and S3,S4,S5).
As demonstrated in Figure 6, 4 of the top 5 combinations
identified were multifunctional for volunteer 53 s in response to
autologous stimulation. All of the top 5 combinations for volunteer
53 s produced MIP-1b (either singly or in combination with other
cytokines). The top 5 combinations for volunteer 53 s were the
same for both autologous and HLA-E restricted stimulation
(Figures 6 & 7). In contrast, in volunteer 54 s the top combinations
differed depending on the type of stimulation (Figures S3 and S4).
Volunteer 50 s did not respond to HLA-E restricted stimulation.
IL-17A Producing Cells are Multifunctional and co-
produce IL-2, IFN-c, TNF-a, and/or MIP-1b
As shown above, IL-17A production was detected in all of the
responding volunteers following stimulation with both autologous
and HLA-E restricted cells (Figures 2, 4, and S3,S4,S5). To further
characterize the IL-17A producing cells, we studied their
multifunctional characteristics in further detail. We found that
virtually all of the IL-17A producing cells were multifunctional, co-
producing IL-2, IFN-c, TNF-a, and/or MIP-1b (Figure 8). All IL-
17A+ populations were IL-10-. We identified 4 IL-17A+
populations: IL-17A+ IL-2+ IFN-c+ TNF-a+ MIP-1b- (‘‘quadru-
ple positive’’), IL-17A+ IL-2- IFN-c+ TNF-a+ MIP-1b- (‘‘triple
positive’’), IL-17A+ IL-2+ IFN-c+ TNF-a+ MIP-1b+ (‘‘quintuple
positive’’), and IL-17A+ IL-2- IFN-c+ TNF-a+ MIP-1b+ (‘‘qua-
druple positive’’). IL-17A production by volunteer 53 s was
predominantly by quintuple-positive cells co-producing IL-17A,
IL-2, IFN-c, TNF-a, and MIP-1b at most time points. The peak of
the quintuple-positive cells was on day 42 post immunization
following stimulation with S. Typhi-infected autologous B-LCL
(3.91% of CD8+ CD69+ TEM) and day 56 post immunization
following stimulation with S. Typhi-infected HLA-E restricted cells
(2.01% of CD8+ CD69+ TEM) (Figure 8 A & B). Quadruple-
positive (IL-17A+ IL-2- IFN-c+ TNF-a+ MIP-1b+) cells were also
present at lower percentages with similar kinetics. Additionally, at
day 10 post immunization there was no MIP-1b; however
production of IL-17A+ IL-2+ IFN-c+ TNF-a+ MIP-1b- and IL-
17A+ IL-2- IFN-c+ TNF-a+ MIP-1b- populations were identified
(although at lower levels) (Figure 8 A & B). Volunteer 54 s did not
show any MIP-1b production except on day 7 post immunization
(Figure 2C and Figure 4C). IL-17A+ populations reflected this
with the predominant populations being quadruple positive (IL-
17A+ IL-2+ IFN-c+ TNF-a+ MIP-1b-) followed by triple positive
(IL-17A+ IL-2- IFN-c+ TNF-a+ MIP-1b-) TEM cells at all time-
points except at day 7 post immunization (Figure 8 C & D). MIP-
1b was not measured in volunteer 50 s so only 2 populations were
identified. These populations varied only in their production of IL-
2 (Figure 8 E).
Unsupervised Analysis Using Flow Cytometry Clustering
without K (FLOCK) Confirms the Multifunctionality of
S. Typhi-specific CD8+ IL-17A+ T Cells
To further examine the multifunctional IL-17A+ populations
identified by conventional, user-guided, flow cytometry analyses,
we used the novel unsupervised analysis program FLOCK.
FLOCK uses computational methods to determine the number
of unique populations in multidimensional flow cytometry data
[36]. A subset of time-points (days 0, 7, 10, and 42 post
immunization) for volunteers 53 s and 54 s following stimulation
Figure 3. Detection of intracellular cytokines/chemokines produced by CD8+ T cell memory subsets in response to stimulation with
S. Typhi-infected HLA-E restricted cells. Histograms from a representative volunteer (53 s at day 7 post infection) showing the production of 6
cytokines/chemokines by memory T cell subsets following stimulation with S. Typhi-infected AEH cells. CD69 (marker of recent activation) is displayed
on the y-axis and each of the 6 cytokines/chemokines measured are displayed on the x-axes. Column 1 represents total CD8+ T cells, column 2
represents TCM, column 3 represents TN, column 4 represents TEM, and column 5 represents TEMRA. The percentage of positive cells is shown for the
indicated region in each cytogram.
doi:10.1371/journal.pone.0038408.g003
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were analyzed for intracellular detection of IL-10, IL-17A, IL-2,
IFN-c, TNF-a, and MIP-1b by conventional, user-guided
methods (Figures 1, 6, and S3) were analyzed by FLOCK. Prior
to FLOCK analyses, gating was performed as described in Figure
S1 to select CD3+ CD8+ TEM events. Data for the 4 selected time-
points for each volunteer were uploaded to the ImmPort website
(http://immport.niaid.nih.gov) and FLOCK analyses performed.
The number of unique populations varied at different time-points
and between volunteers (9–29 individual populations). In order to
compare data across time-points and between volunteers, a cross-
sample analysis was performed. In this cross sample analysis, the
populations identified in a single sample (volunteer 53 s day 10
post infection following stimulation with S. Typhi-infected B-LCL)
were applied to all samples. Six unique CD69+ (i.e., recently
activated) populations were identified (Figure 9 A). All 6
populations were negative for IL-10 production. MIP-1b produc-
tion was dependent on the time-point and volunteer. In other
words, at those time-points for volunteer 53 s at which
intracellular MIP-1b was detected (days 7 and 42 post immuni-
zation), MIP-1b was produced by populations 1, 3, 5, and 6.
However, for volunteer 54 s, only populations 3 and 5 produced
MIP-1b on day 7 post immunization. Population 4 was negative
for all cytokines/chemokines measured. Populations 1 and 6 were
IL-17A+ (Figure 9). The IL-17A+ populations identified were both
multifunctional co-producing IL-2, IFN-c, TNF-a, and/or MIP-
1b (Figure 9). Population 1 was IL-10- IL-17A+ IL-2+ IFN-c+
TNF-a+ MIP-1b+/2, while population 6 was IL-10- IL-17A+ IL-
2- IFN-c+ TNF-a+ MIP-1b+/2 (Figure 9). Figure 9 depicts a
representative sample which did not produce MIP-1b (volunteer
53 s day 10 post immunization). The IL-17A+ populations that
were identified differed in their production of IL-2.
In addition to identifying multifunctional cells, FLOCK analysis
distinguished bright (++) and dim (+) populations of IFN-c and
TNF-a based on mean fluorescence intensity (MFI) (Figure 9 A).
Brighter intensity of staining indicates higher intracellular cytokine
content. Populations 1, 5, and 6 stained brightly for IFN-c, while
populations 1 and 6 stained brightly for TNF-a (Figure 9). These
data from unsupervised analysis indicate that IL-17A-producing
cells produce high levels of both IFN-c and TNF-a.
Figure 10A shows 3-dimensional representation of IL-2 (x-axis),
IFN-c (y-axis), and TNF-a (z-axis) for 4 of the CD69+ populations
(populations 1, 2, 4, and 6). Each panel shows an approximately
30u rotation around the z-axis. Population 4 (purple) is negative for
all measured cytokines, population 2 (lime green) is IFN-c and
TNF-a dim, while populations 1 (pink) and 6 (aqua) are IFN-c and
TNF-a bright. Populations 1 and 6 are both IL-17A+ but differ in
their production of IL-2 as described above (Figures 9A and B and
10A).
The net percentage of positive cells for each population at the 3
time-points, as determined by cross-sample analysis, is shown in
Figure 10B. IL-17A+ multifunctional cells were identified at days
7, 10, and 42 post immunization for volunteer 53 s with a peak at
day 10 post immunization (Figure 10B). Volunteer 54 s had low
levels of IL-17A+ multifunctional cells on day 7 post immuniza-
tion, but the predominant response was at day 42 post
immunization which correlates with the later peak cytokine
production previously demonstrated for volunteer 54 s (Figure 2C).
Discussion
Here we demonstrate the presence and persistence of multi-
functional IL-17A producing S. Typhi-specific CD8+ T cells in
response to both S. Typhi-infected autologous B-LCL and HLA-E
restricted stimulation. Multifunctional IL-17A+ cells demonstrated
multiphasic kinetics and were still detectable one year after
immunization. We identified quadruple and quintuple positive
CD8+ TEM and TEMRA IL-17A producing cells that co-produce
pro-inflammatory cytokines/chemokines IL-2, IFN-c, TNF-a,
and/or MIP-1b but not IL-10. These multifunctional populations
were confirmed using unsupervised flow cytometric analysis with
FLOCK.
IL-17 has been increasingly implicated in host responses against
intracellular pathogens [19]. Specifically, the importance of IL-17
in mucosal immune responses to intracellular enteric pathogens
has been demonstrated in animal models [20,21]. It was shown
that depletion of Th17 cells during simian immunodeficiency virus
(SIV) infection results in increased dissemination of Salmonella
Typhimurium from the gut [20]. Additionally, antigen-specific IL-
17A+ cells were identified in response to Salmonella Enteriditis
infection and IL-17A knockout mice had an elevated bacterial
burden in the liver and spleen as compared to wild-type mice [37].
Thus, it was of great importance to initiate studies to evaluate
whether IL-17A might play a role in protection from S. Typhi.
Because the gastrointestinal mucosa is the first point of contact for
S. Typhi, mucosal immune responses are likely to play an
important role in protection. This is to our knowledge, the first
report of IL-17A production in response to S. Typhi, both to S.
Typhi-infected autologous targets, as well as HLA-E restricted
stimulation. The presence of S. Typhi-specific CD8+ T cells
producing IL-17A suggests that these cells may play a role in the
mucosal response. CD8+ T cells with characteristics of the Th17
lineage, Tc17, have been described in the setting of chronic
hepatitis C virus infection [25]; however, in these studies,
stimulation with phorbol myristate acetate (PMA) and ionomycin
was used rather than specific antigen. Thus, the results presented
in this manuscript are, to our knowledge, the first demonstration in
humans of the presence of CD8
+ Tc17 cells responsive to antigens
from infectious agents.
Multifunctional T cells, i.e., those producing 2 or more cytokines
simultaneously, have been shown to produce higher levels of
individual cytokines, have enhanced function, and are more likely
to correlate with protection from disease, when compared to single
cytokine producing cells [29,30,31]. Although T cells co-produc-
ing IL-17A with IFN-c or TNF-a in response to PMA/ionomycin
stimulation have been identified [38,39], to our knowledge, this is
the first study to examine the simultaneous production of IL-17A
with 5 other cytokines/chemokines, which play key roles in
inflammatory processes, in a human-pathogen specific system. Of
note, unsupervised flow cytometric FLOCK analysis showed
higher levels of IFN-c and TNF-a being produced by IL-17A-
producing multifunctional cells (i.e., multifunctional IL-17A+
populations are bright for IFN-c and TNF-a). In addition, we
Figure 4. Kinetics of intracellular cytokine/chemokine production following stimulation of PBMC with S. Typhi-infected HLA-E
restriced cells. Intracellular cytokine/chemokine production is shown as the percentage of positive cells. Responses are expressed as net values with
day 0 subtracted to normalize for differences in base-line responses to S. Typhi in different volunteers. A) CD8+ TEM cells for volunteer 53 s B) CD8+
TEMRA cells for volunteer 53 s C) CD8+ TEM cells for volunteer 54 s D) CD8+ TEMRA cells for volunteer 54 s E) CD8+ TEM cells for volunteer 50 s F) CD8+
TEMRA cells for volunteer 50 s. Increases of .0.5% cytokine positive cells over uninfected targets were found to be statistically significant (P,0.01). *
MIP-1b not measured.
doi:10.1371/journal.pone.0038408.g004
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cells and that the predominant IL-17A+ responses were IL-17A+
IL-2+ IFN-c+ TNF-a+ MIP-1b+/2 as assessed by both super-
vised (FCOM) and unsupervised (FLOCK) flow cytometric
analyses. The co-production of IL-17A with cytokines typically
associated with Tc1 responses, suggest that the Tc17 lineage is not
as distinct in humans as in vitro and animal studies have previously
suggested.
Multiphasic kinetics have previously been demonstrated in
response to Ty21a immunization following stimulation in an
HLA-E restricted manner [13]. Here we confirm and extend these
findings by showing that multiphasic kinetics are also typical of
responses to autologous stimulation with B-LCL. Interestingly,
despite their bi- or tri-phasic nature, the kinetics of responses to
autologous stimulation and HLA-E restricted stimulation differed.
HLA-E is a non-classical major histocompatibility (MHC)
molecule which is highly conserved [40] and it is expressed
ubiquitously on PBMC (at various levels depending on the
individual cell types) in combination with classical MHC
molecules [41]. Given the differences in kinetics between
autologous and HLA-E restricted stimulation, as well as the fact
that volunteer 50 s showed responses to autologous stimulation but
not to HLA-E restricted stimulation, our results clearly indicate
that while HLA-E restricted responses may contribute to the
responses seen when PBMC were stimulated with S. Typhi-
infected autologous B-LCL, they represent only a portion of these
responses. It will be important to confirm these findings using
different targets such as autologous blasts. However, these data are
supported by the fact that in previous studies, monoclonal
antibodies against HLA-E were only able to partially block CTL
activity against S. Typhi-infected targets, while monoclonal
antibody against a pan-MHC class I marker (W6/32) showed
almost complete abrogation of CTL against S. Typhi-infected
targets [9]. Moreover, the observations that at different times after
immunization there are considerable differences in the effector
subsets that respond to autologous and HLA-E restricted S. Typhi-
infected cells raises the likely possibility that various effector cells
might contribute differently to the host defense at various times
after exposure. These observations also point to the importance of
the timing of specimen collection following immunization and its
impact on the magnitude of effector immune responses which can
be measured. Finally, it is important to mention that these data
confirm and extend previous observations on the longevity of CMI
responses (at least 1 year) elicited following immunization with
Ty21a and other attenuated typhoid vaccine candidates [12,13].
The significance of the multiphasic responses observed is not
entirely clear; however, it is possible that the decline in the levels of
cytokine producing S. Typhi-specific CD8+ T cells at various times
could represent these cells homing cells to the gut. Previous studies
have, in fact, shown expression of gut-homing molecules on S.
Typhi-specific CD8+ T cells [12,17]. While these multiphasic
responses have previously been described for HLA-E restricted
responses [13], this is the first report of multiphasic kinetics in
response to autologous stimulation over the course of 1 year post-
immunization with the Ty21a typhoid vaccine. As has previously
been shown, the responses following HLA-E restricted stimulation
peaked as early as 4–7 days post immunization which is earlier
than typically expected for CMI responses [13]. Interestingly, in 2
of the 3 responding volunteers (50 s and 53 s), a peak as early as
days 4–7 post immunization was observed in response to
autologous stimulation as well. In summary, multifunctional IL-
17A+ CD8+ T cells display multiphasic kinetics in response to
both classical and non-classical MHC restricted stimulation. These
responses persist at least 1 year after immunization. Future studies
in which the presence of these multifunctional Tc17 responses are
evaluated in the context of clinical outcome following challenge of
volunteers with wild-type S. Typhi will provide key information to
assess the role of multifunctional cells producing high levels of IL-
17A and other cytokines in protection from infection. These
studies are likely to contribute to accelerate the development of
much needed novel typhoid vaccines.
Supporting Information
Figure S1 Gating strategy used for flow cytometry
analyses. Lymphocytes were gated based on forward and side
scatter, followed by doublet exclusion. Live (ViViD negative)
CD14- CD19- CD3+ T cells were then selected. CD8+ CD4- cells
were further divided into memory subsets based on CD62L and
CD45RA expression. Naı ¨ve T cells (TN; CD62L+ CD45RA+), T
central memory cells (TCM; CD62L+ CD45RA-), T effector
memory (TEM; CD62L- CD45RA-), and T effector memory
CD45RA+ (TEMRA; CD62L- CD45RA+)
(TIF)
Figure S2 Kinetics of cytokine/chemokine production
following stimulation of PBMC with S. Typhi-infected
autologous B-LCL (non-responders and a non-immu-
nized control). Responses are expressed as net values with day 0
subtracted to normalize for differences in base-line responses to S.
Typhi in different volunteers. A) CD8+ TEM cells for volunteer
48 s B) CD8+ TEMRA cells for volunteer 48 s C) CD8+ TEM cells
for volunteer 52 s D) CD8+ TEMRA cells for volunteer 52 s E)
CD8+ TEM cells for volunteer 196 s F) CD8+ TEMRA cells for
volunteer 196 s * MIP-1b not measured
(TIF)
Figure S3 Multifunctional CD8+ TEM responses to S.
Typhi-infected autologous B-LCL. A) Scatter plot showing all
combinations of the 6 cytokines/chemokines measured that were
positive at one or more time points for volunteer 54 s. Increases of
.0.5% cytokine positive cells over uninfected targets were found
to be statistically significant (P,0.01). Each point represents a
single time-point and the median value is denoted by a horizontal
bar. The cyokine/chemokine combinations with the top 2 median
values are indicated by red squares. Median values of the subsets
of multifunctional cells that show a significant difference (*P,0.05,
**P,0.01), when compared to the subsets without asterisks, are
indicated. B) Kinetics of the top 2 populations (as determined by
median value) over time.
(TIF)
Figure S4 Multifunctional CD8+ TEM responses to S.
Typhi-infected HLA-E restricted cells. A) Scatter plot
Figure 5. Kinetics of intracellular IL-17A production following stimulation with either S. Typhi-infected autologous B-LCL or HLA-E
restricted cells. Intracellular cytokine/chemokine production is shown as the percentage of positive cells. Responses are expressed as net values
with day 0 subtracted to normalize for differences in base-line responses to S. Typhi in different volunteers. Responses to S. Typhi-infected
autologous B-LCL are indicated by a filled square (&) and responses to S. Typhi-infected HLA-E restricted cells are indicated by open triangles (n). A)
CD8+ TEM cells for volunteer 53 s B) CD8+ TEMRA cells for volunteer 53 s C) CD8+ TEM cells for volunteer 54 s D) CD8+ TEMRA cells for volunteer 54 s E)
CD8+ TEM cells for volunteer 50 s F) CD8+ TEMRA cells for volunteer 50 s. Increases of .0.5% cytokine positive cells over uninfected targets were found
to be statistically significant (P,0.01).
doi:10.1371/journal.pone.0038408.g005
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that were positive at one or more time points for volunteer 54 s.
Net increases of .0.5% cytokine positive cells over uninfected
targets were found to be statistically significant (P,0.01). Each
point represents a single time-point and the median value is
denoted by a horizontal bar. The cyokine/chemokine combina-
tions with the top 2 median values are indicated by red rectangles.
Median values of the subsets of multifunctional cells that show a
significant difference (*P,0.05, **P,0.01), when compared to the
subsets without asterisks, are indicated. B) Kinetics of the top 2
populations (as determined by median value) over time.
(TIF)
Figure 6. Multifunctional CD8+ TEM responses to S. Typhi-infected autologous B-LCL. A) Scatter plot showing all combinations of the 6
cytokines/chemokines measured that were positive at one or more time points for representative volunteer 53 s. Increases of .0.5% positive cells
over uninfected targets were statistically significant (P,0.01). Each point represents a single time-point and the median value is denoted by a
horizontal bar. The cyokine/chemokine combinations with the top 5 median values are indicated by red rectangles. Median values of the subsets of
multifunctional cells that show a significant difference (**P,0.01), when compared to the subsets without asterisks, are indicated. B) Kinetics of the
top 5 populations (as determined by median value) over time.
doi:10.1371/journal.pone.0038408.g006
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PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e38408Figure S5 Multifunctional CD8+ TEM responses to S.
Typhi-infected autologous B-LCL. A) Scatter plot showing all
combinations of the 5 cytokines/chemokines measured (MIP-1b
was not measured) that were positive at one or more time points
for volunteer 50 s. Net increases of .0.5% cytokine positive cells
over uninfected targets were found to be statistically significant
(P,0.01). Each point represents a single time-point and the
median value is denoted by a horizontal bar. The cyokine/
chemokine combinations with the top 3 median values are
indicated by red rectangles. Median values of the subsets of
multifunctional cells that show a significant difference (*P,0.05,
**P,0.01, ***P#0.001), when compared to the subsets without
asterisks, are indicated. B) Kinetics of the top 3 populations (as
determined by median value) over time.
(TIF)
Figure 7. Multifunctional CD8+ TEM responses to S. Typhi-infected HLA-E restricted cells. A) Scatter plot showing all combinations of the 6
cytokines/chemokines measured that were positive at one or more time points for representative volunteer 53 s. Increases of .0.5% positive cells
over uninfected targets were statistically significant. Each point represents a single time-point and the median value is denoted by a horizontal bar.
The cyokine/chemokine combinations with the top 5 median values are indicated by red rectangles. Median values of the subsets of multifunctional
cells that show a significant difference (**P,0.01, ***P,0.001), when compared to the subsets without asterisks, are indicated. B) Kinetics of the top 5
populations (as determined by median value) over time.
doi:10.1371/journal.pone.0038408.g007
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PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e38408Figure 8. Multifunctional CD8+ TEM IL-17A+ populations. Kinetics of multifunctional IL-17A+ populations (if net .0.5%) following stimulation
with either S. Typhi-infected autologous B-LCL (A, C, & E) or HLA-E restricted cells (B & D). Net increases of .0.5% cytokine positive cells over
uninfected targets were found to be statistically significant (P,0.01). 50 s had no response to HLA-E restricted stimulation. * MIP-1b was not
measured.
doi:10.1371/journal.pone.0038408.g008
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PLoS ONE | www.plosone.org 14 June 2012 | Volume 7 | Issue 6 | e38408Figure 9. CD69+ populations identified by unsupervised FLOCK analyses. CD3+ CD8+ TEM events following S. Typhi-infected autologous B-
LCL stimulation were uploaded to ImmPort for FLOCK analyses. A) Cytokine/chemokine production patterns of the 6 CD69+ populations identified by
FLOCK. B) Histograms showing FLOCK of representative volunteer 53 s at day 10 post immunization with the IL-17A+ populations highlighted
(population 1- pink and population 6- aqua).
doi:10.1371/journal.pone.0038408.g009
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